Press release
US DNA Methylation Sequencing Market Trends 2024-2031: Innovations in PCR and Microarray Technologies Boost Clinical and Research Applications
Leander, Texas and United States : The DNA Methylation Sequencing Market was valued at US$ 622.1 million in 2024 and is projected to reach US$ 2,115.9 million by 2033, growing at a CAGR of 14.8% during the forecast period. Growth is driven by increasing investment in epigenetics, wider use of sequencing-based diagnostics, and rising demand for accurate biomarker identification in oncology and other diseases.The market holds a strong position within the country's expanding molecular diagnostics landscape. Advancements in high-throughput sequencing platforms, improved sample preparation methods, and refined data analysis tools are supporting broader adoption of methylation profiling in early disease detection, drug research, and personalized treatment strategies. This momentum is helping strengthen the role of methylation sequencing as an essential component of modern clinical and research applications.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/dna-methylation-sequencing-market?sai-v
The DNA methylation sequencing market involves advanced genomic technologies used to analyze methylation patterns across DNA, enabling precise insights into gene regulation, disease mechanisms, and biomarker discovery.
Key Developments
United States
✅ April 2025-A major sequencing-instrument company licensed advanced deep-learning epigenetic models to improve detection of DNA base modifications (like 5hmC and 5mC) directly in native DNA, supporting higher-resolution methylation sequencing.
✅ April 2025 - A life-sciences tools company showcased a combined DNA methylation-plus-cancer-panel platform, capable of profiling methylation and other genomic features from a single sample-designed to accelerate cancer epigenetics research.
✅ May 2025-Researchers published a cross-platform methylation classifier that predicts tissue and disease-of-origin from cell-free DNA, improving the feasibility of methylation-based liquid biopsy diagnostics.
Mergers & Acquisitions
United States
✅ April 2025 - A sequencing-technology company secured a license for next-generation methylation models and bioinformatics IP, strengthening its methylation sequencing and analysis pipeline.
Key Players:
Abcam plc | Active Motif Inc. | Agilent Technologies Inc. | Bio-Rad Laboratories Inc. | Diagenode Diagnostics SA | EpiGentek Group Inc. | Exact Sciences Corporation | F. Hoffmann-La Roche Ltd. | Illumina Inc. | Merck KGaA | New England Biolabs Inc.
Key Highlights:
• Abcam plc - A leading provider of antibodies and epigenetics research tools, supporting strong demand from biopharma and academic research laboratories.
• Active Motif Inc. - Specializes in chromatin biology and epigenetics reagents, driving market growth through innovation in ChIP, ATAC-seq, and DNA methylation products.
• Agilent Technologies Inc. - Strengthening its position in the epigenetics and genomics markets with advanced sequencing, sample prep, and analytical instrumentation.
• Bio-Rad Laboratories Inc. - Expanding its portfolio of gene expression, qPCR, and sequencing workflow solutions widely adopted in molecular and clinical research.
• Diagenode Diagnostics SA - Focused on high-quality epigenetics assays and diagnostics kits, supporting growing use of DNA methylation analysis in clinical settings.
• EpiGentek Group Inc. - Known for specialized epigenetics kits and reagents, enabling rapid growth in DNA methylation, histone modification, and chromatin analysis research.
• Exact Sciences Corporation - Advancing molecular diagnostics platforms with strong emphasis on epigenetic biomarkers for early cancer detection.
• F. Hoffmann-La Roche Ltd. - A global leader in molecular diagnostics and sequencing, driving adoption of epigenetic testing in oncology and personalized medicine.
• Illumina Inc. - Dominates the sequencing market with solutions that accelerate epigenome mapping, methylation sequencing, and genome-wide analysis.
• Merck KGaA - Offers an extensive range of epigenetics reagents and tools, supporting broad adoption across pharmaceutical R&D and clinical research.
• New England Biolabs Inc. - A key supplier of epigenetics enzymes, methylation tools, and sequencing reagents widely used in basic and applied genetic r
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=dna-methylation-sequencing-market?sai-v
Market Drivers & Growth
• Rising demand for precise epigenetic profiling in cancer research, diagnostics, and personalized medicine.
• Increased adoption of next-generation sequencing (NGS) technologies for high-resolution methylation analysis.
• Growing focus on early disease detection and biomarker discovery to support targeted therapies.
• Expansion of pharmaceutical and biotech R&D activities, boosting the need for advanced methylation sequencing tools.
• Government and institutional funding supporting large-scale epigenomics projects and precision healthcare initiatives.
Industrial Advances & Developments
• Development of high-throughput, low-input, and single-cell methylation sequencing platforms for improved sensitivity.
• Introduction of cost-efficient library preparation kits simplifying workflow and reducing sample processing time.
• Advancements in whole-genome bisulfite sequencing (WGBS) and enzymatic methylation sequencing for higher accuracy.
• Integration of AI-driven bioinformatics tools to enhance methylation data interpretation and clinical relevance.
• Growing partnerships between sequencing technology providers, research institutes, and diagnostic companies to develop methylation-based assays.
Regional Insights
• North America: Strong leadership driven by advanced genomic research infrastructure, high R&D investment, and adoption of precision medicine.
• Europe: Robust growth supported by government-funded epigenetics programs and strong presence of genomic technology companies.
• Asia-Pacific: Fastest-growing region due to expanding biotech ecosystems, rising cancer incidence, and increasing adoption of NGS platforms in China, Japan, and India.
• Latin America: Moderate growth with improving research capabilities and adoption of modern sequencing technologies in leading academic centers.
• Middle East & Africa: Gradual expansion driven by investments in medical genomics, oncology research, and emerging healthcare modernization initiatives.
Key Segments:
➥ By Product
Instruments | Consumables | Software
Consumables lead the market due to recurrent usage across research workflows, while Instruments drive significant value through advanced platforms. Software adoption grows with increased need for data analytics and workflow automation.
Market Attractiveness: Consumables - High | Instruments - Moderate | Software - Emerging
➥ By Technology
Polymerase Chain Reaction (PCR) | Microarray | Others
PCR dominates owing to its high sensitivity and broad applicability in genomics and clinical diagnostics. Microarray usage remains steady in gene expression profiling, while Others include emerging sequencing and analytical technologies.
Market Attractiveness: PCR - High | Microarray - Moderate | Others - Emerging
➥ By Application
Oncology Research | Non-Oncology Research | Clinical Application | Translational Research
Oncology Research remains the largest segment due to strong investment in cancer genomics. Clinical Applications grow rapidly with rising diagnostic demand, while Translational Research bridges lab discoveries with real-world applications.
Market Attractiveness: Oncology - High | Clinical - High | Translational - Moderate | Non-Oncology - Moderate
➥ By End-User
Pharmaceutical & Biotechnology Companies | Research Centers | Contract Research Organizations (CROs)
Pharmaceutical & Biotechnology companies dominate driven by extensive R&D pipelines, while CROs expand quickly due to outsourcing trends. Research Centers remain critical for foundational and academic research.
Market Attractiveness: Pharma/Biotech - High | CROs - High | Research Centers - Moderate
Speak to our analyst and get customization in the report as per your requirements: https://www.datamintelligence.com/customize/dna-methylation-sequencing-market?sai-v
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release US DNA Methylation Sequencing Market Trends 2024-2031: Innovations in PCR and Microarray Technologies Boost Clinical and Research Applications here
News-ID: 4272870 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
North America Fermented Feed Ingredients Market Projected to Hit USD 70.39 Billi …
Leander, Texas and TOKYO, Japan - The North America Fermented Feed Ingredients Market was valued at approximately USD 36.71 billion in 2024 and is expected to reach USD 70.39 billion by 2030, growing at a CAGR of 11.42% during the forecast period 2025-2030.
The growth in this market is primarily driven by the rising demand for natural and sustainable feed additives to improve animal health and productivity, increasing consumer preference for…
Global Food Authentication Testing Market Set to Expand at 8.5% CAGR, Projected …
Leander, Texas and Tokyo, Japan - Nov 17, 2025
The global food authentication testing market reached USD 8.7 billion in 2022 and is expected to reach USD 16.7 billion by 2030, growing with a CAGR of 8.5% during the forecast period 2024-2031. This robust growth is propelled by increasing incidents of food fraud, stringent regulatory requirements for food safety and labeling, rising consumer awareness about food authenticity, and advancements in…
United States Sustainable textile fibers Industry is projected CAGR of 8% - Driv …
Leander, Texas and TOKYO, Japan- The U.S. sustainable textile fibers market is estimated at approximately USD 2.87 billion in 2025, growing at a projected CAGR of around 8% through 2033.
Global Sustainable Textile Fibers Market reached US$ 48.15 billion in 2023 and is expected to reach US$ 71.65 billion by 2031, growing with a CAGR of 5.09% during the forecast period 2024-2031.
The market is driven by, U.S. consumers are increasingly…
Beauty and Personal Care Products Industry Sector to hit US$ 624.2 billion by 20 …
WILMINGTON, DE, UNITED STATES:
The U.S. beauty & personal care market was valued at US$ 97B in 2024, expected to rise to US$ 145B by 2032 at a CAGR of 5.1%.
Japan's beauty & personal care market stood at US$ 41B in 2024, projected to reach US$ 57B by 2032, growing at a CAGR of 4.2%.
Global Beauty and Personal Care Products Market reached US$ 487.5 billion in 2022 and is expected to…
More Releases for DNA
High-Quality Plasmid DNA Fuels Growth in Global DNA Plasmid Manufacturing Market
🌍 Market Overview
The DNA Plasmid Manufacturing Market is experiencing robust growth as advancements in cell & gene therapy, DNA vaccines, and genetic engineering continue to expand globally. Plasmid DNA plays a critical role as a raw material in the development of advanced therapies, fueling demand across biopharmaceutical research and production.
Key factors driving the market include:
Increasing adoption of gene and cell therapies
Rising prevalence of chronic and rare genetic disorders
Expansion of DNA-based…
DNA Synthesis Market Increasing Demand for Synthetic Genes and DNA Sequences
As demonstrated by Precision Business Insights (PBI), the latest report, the global DNA synthesis market was valued at USD 3,702.0 million in 2023 and is expected to reach USD 10,289.5 million by 2029, growing at a CAGR of 18.6% during the forecast period 2024-2030. The key drivers for the growth of the global DNA synthesis market include increasing demand for synthetic genes and DNA sequences, growing applications in the agriculture…
Wealth DNA Code Review Legit Price? (Wealth Manifestation DNA Code Audio Frequen …
Wealth DNA Code Wealth DNA Code is a digital program with seven minutes of soundtracks that manifest and listen to daily to activate the "Wealth DNA," which is part of your DNA to help you attract wealth by making money a part of your mentality and making your dreams to come true.
https://bit.ly/Visit-The-Official-Website-Here-To-Order-Wealth-DNA-Code
Making money, creating assets as well as increasing wealth are the primary objectives that every human being has to…
DNA Paternity Testing Market Size [2022-2029] -DNA Diagnostics Center, EasyDNA, …
A recent market research report added to repository of MR Accuracy Reports is an in-depth analysis of global DNA Paternity Testing. On the basis of historic growth analysis and current scenario of DNA Paternity Testing place, the report intends to offer actionable insights on global market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insights drawn from data serve as excellent…
DNA Paternity Testing Market Trends 2020 | Growth by Top Companies: DNA Diagnost …
The report begins with the overview of the DNA Paternity Testing Market and offers throughout development. It presents a comprehensive analysis of all the regional and major player segments that gives closer insights upon present market conditions and future market opportunities along with drivers, trending segments, consumer behaviour, pricing factors and market performance and estimation. The forecast market information, SWOT analysis, DNA Paternity Testing market scenario, and feasibility study are…
DNA Paternity Testing Market Rapidly Growing in Healthcare, Competitor Analysis …
The exclusive research report on the Global DNA Paternity Testing Market 2020 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market. Global DNA Paternity Testing Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe.
Overview of Global DNA Paternity Testing Market:
This report studies the Global DNA Paternity Testing…
